1 | 045251016 | - | - | - | - | [1] 19 19 💬 |
2 | 1- Deoxygalactonojirimycin | - | - | - | - | [1] 19 19 💬 |
3 | 1-Deoxygalactonojirimycin | [1] Migalastat Migalastat | [1] Migalastat
Migalastat
💬 | - | - | [1] 19 19 💬 |
4 | 1-deoxygalactonojirimycin hydrochloride | [1] Migalastat Migalastat | [1] Migalastat
Migalastat
💬 | - | - | [1] 19 19 💬 |
5 | 12S-IT | - | - | - | - | [1] 19 19 💬 |
6 | 15-0 H20 | - | - | - | - | [2] 6 6, 19 💬 |
7 | 2(S)-(ACETYLAMINO)-4-METHYLPENTANOIC ACID | - | - | - | - | [2] 19 19, 65 💬 |
8 | 2-aminoethanethiol | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [2] 19 19, 299 💬 |
9 | 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN | [2] Betadex Betadex, Hydroxypropyl betadex | [1] Betadex
Betadex
💬 | - | - | [1] 19 19 💬 |
10 | 26 common Fabry mutation types in Taiwan | - | - | - | - | [1] 19 19 💬 |
11 | 4D-310 | - | - | - | - | [1] 19 19 💬 |
12 | 500 0500 0 | - | - | - | - | [1] 19 19 💬 |
13 | 89 Zirconium Recombinant Human Alpha-N-Acetylglucosaminidase (rhNAGLU) (radiolabeled) | - | - | - | - | [1] 19 19 💬 |
14 | 89Zr-SBC-103 | - | - | - | - | [1] 19 19 💬 |
15 | [14C] AT1001 | - | - | - | - | [1] 19 19 💬 |
16 | A (migalastat) | [1] Migalastat Migalastat | [1] Migalastat
Migalastat
💬 | - | - | [1] 19 19 💬 |
17 | A16AB04 | - | - | - | - | [1] 19 19 💬 |
18 | A16AX06 | - | - | - | - | [1] 19 19 💬 |
19 | AAV2/8.TBG.hARSB | - | - | - | - | [1] 19 19 💬 |
20 | AAV2CUhCLN2 (3x10^12 particle units) | - | - | - | - | [1] 19 19 💬 |
21 | AAV9-CAG-coh-SGSH | - | - | - | - | [1] 19 19 💬 |
22 | AAV9-GLB1 | - | - | - | - | [1] 19 19 💬 |
23 | AAVrh.10-hMPSIIIA | - | - | - | - | [1] 19 19 💬 |
24 | AAVrh.10cuARSA | - | - | - | - | [1] 19 19 💬 |
25 | AAVrh.10CUCLN2 | - | - | - | - | [1] 19 19 💬 |
26 | AAVrh.10CUhCLN2 vector 2.85x10^11 genome copies | - | - | - | - | [1] 19 19 💬 |
27 | AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies | - | - | - | - | [1] 19 19 💬 |
28 | Abatacept | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬 | [2] CD80 CD80, CD86 💬 | [13] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [26] 11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
29 | Abcertin | - | - | - | - | [1] 19 19 💬 |
30 | ABO-101 | - | - | - | - | [1] 19 19 💬 |
31 | ABO-102 | - | - | - | - | [1] 19 19 💬 |
32 | Accupro | - | - | - | - | [1] 19 19 💬 |
33 | Accuretic | [1] Quinapril Quinapril | [1] Quinapril
Quinapril
💬 | [1] ACE ACE 💬 | [6] Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 19 19 💬 |
34 | Acetyl-l-leucine | [2] L-Acetylleucine L-Acetylleucine, Leucine | [1] Leucine
Leucine
💬 | - | - | [2] 19 19, 65 💬 |
35 | Acetylcysteine | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬 | - | - | [21] 6 6, 13, 19, 20, 21, 49, 51, 53, 58, 63, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337 💬 |
36 | ACT-434964 | - | - | - | - | [1] 19 19 💬 |
37 | Adalimumab | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [17] 19 19, 37, 40, 41, 46, 56, 84, 96, 97, 107, 160, 164, 222, 226, 269, 270, 271 💬 |
38 | ADENO-ASSOCIATED VIRAL (AAV) SEROTYPE 8 (AAV2/8) VECTOR WITH LIVER-SPECIFIC THYROXINE-BINDING GLOBULIN (TBG) PROMOTER, DRIVING THE EXPRESSION OF THE HUMAN ARSB GENE | [1] Levothyroxine Levothyroxine | [1] Levothyroxine
Levothyroxine
💬 | [2] THRA THRA, THRB 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | [1] 19 19 💬 |
39 | Adeno-associated viral vector serotype 9 containing the human N-acetyl-alpha-glucosaminidase gene | - | - | - | - | [1] 19 19 💬 |
40 | Adeno-associated virus (AAV) serotype rh.10 expressing human betagalactosidase (AAVrh.10-CAG-betagal) | - | - | - | - | [1] 19 19 💬 |
41 | Adeno-associated virus (AAV) serotype rh.10 expressing human betagalactosidase (AAVrh.10-CAG-ßgal) | - | - | - | - | [1] 19 19 💬 |
42 | Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase A cDNA | [1] Agalsidase alfa Agalsidase alfa | [1] Agalsidase alfa
Agalsidase alfa
💬 | [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
43 | Adeno-associated virus serotype 2/6 encoding Human Iduronate 2-sulfatase (hIDS) gene donor vector, SB-A6P-HNT Donor Vector | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬 | [1] IDS IDS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
44 | Adeno-associated virus serotype 2/6 encoding human iduronidase (hIDUA) gene donor vector, SB-A6P-HRL Donor Vector | - | - | - | - | [1] 19 19 💬 |
45 | Adeno-associated virus serotype 2/6 encoding Left side-zinc finger nuclease (ZFN1), SB-A6P-ZLEFT Vector | - | - | - | - | [1] 19 19 💬 |
46 | Adeno-associated virus serotype 2/6 encoding Right side-zinc finger nuclease (ZFN2), SB-A6P-ZRIGHT Vector | - | - | - | - | [1] 19 19 💬 |
47 | Adeno-associated virus serotype hu68 containing the human GALC gene | - | - | - | - | [1] 19 19 💬 |
48 | Adeno-associated virus serotype rh.10 expressing beta-galactosidase | [1] Tilactase Tilactase | [1] Lactase
Lactase
💬 | - | - | [1] 19 19 💬 |
49 | ADMINISTRATION | - | - | - | - | [1] 19 19 💬 |
50 | Adrabetadex | [1] Adrabetadex Adrabetadex | - | - | - | [1] 19 19 💬 |
51 | Afegostat | [1] Afegostat Afegostat | [1] Afegostat
Afegostat
💬 | - | - | [1] 19 19 💬 |
52 | Afegostat tartrate | [1] Afegostat Afegostat | [1] Afegostat
Afegostat
💬 | - | - | [1] 19 19 💬 |
53 | Agalsidase | - | - | - | - | [1] 19 19 💬 |
54 | AGALSIDASE ALFA | [1] Agalsidase alfa Agalsidase alfa | [1] Agalsidase alfa
Agalsidase alfa
💬 | [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
55 | Agalsidase Alpha | [1] Agalsidase alfa Agalsidase alfa | [1] Agalsidase alfa
Agalsidase alfa
💬 | [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
56 | AGALSIDASE BETA | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬 | [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
57 | Agalsidase beta (GZ419828) | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬 | [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
58 | Agalsidase beta (recombinant form) | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬 | [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
59 | Agalsidase beta from Biosidus 1 mg/kg | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬 | [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
60 | AGALSIDASI ALFA | - | - | - | - | [1] 19 19 💬 |
61 | AGALSIDASI BETA | - | - | - | - | [1] 19 19 💬 |
62 | AGT-181 | - | - | - | - | [1] 19 19 💬 |
63 | AGT-181 (HIRMAb-IDUA) | - | - | - | - | [1] 19 19 💬 |
64 | AGT-182 | - | - | - | - | [1] 19 19 💬 |
65 | Aldurazyme | [1] Laronidase Laronidase | [1] Laronidase
Laronidase
💬 | [1] IDUA IDUA 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
66 | Aldurazyme (laronidase) | [1] Laronidase Laronidase | [1] Laronidase
Laronidase
💬 | [1] IDUA IDUA 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [2] 19 19, 256 💬 |
67 | Aldurazyme (Recombinant Human Alpha-L-Iduronidase) | [1] Laronidase Laronidase | [1] Laronidase
Laronidase
💬 | [1] IDUA IDUA 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
68 | ALDURAZYME*INFUS 1FL 5ML 500U | [1] Laronidase Laronidase | [1] Laronidase
Laronidase
💬 | [1] IDUA IDUA 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
69 | ALEMTUZUMAB | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬 | [1] CD52 CD52 💬 | - | [17] 13 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬 |
70 | Alendronate | [1] Alendronic acid Alendronic acid | [1] Alendronic acid
Alendronic acid
💬 | [1] FDPS FDPS 💬 | [4] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [7] 19 19, 41, 46, 50, 271, 274, 299 💬 |
71 | Alendronate sodium | [1] Alendronic acid Alendronic acid | [1] Alendronic acid
Alendronic acid
💬 | [1] FDPS FDPS 💬 | [4] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [2] 19 19, 299 💬 |
72 | Alfa-manosidadas humana recombinante | - | - | - | - | [1] 19 19 💬 |
73 | ALISERIN - 25 MG GRANULATO EFFERVESCENTE 20 BUSTINE | - | - | - | - | [1] 19 19 💬 |
74 | Alpha-galactosidase A | [1] Agalsidase alfa Agalsidase alfa | [1] Agalsidase alfa
Agalsidase alfa
💬 | [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
75 | Ambroxol | [1] Ambroxol Ambroxol | [1] Ambroxol
Ambroxol
💬 | - | - | [2] 6 6, 19 💬 |
76 | Ambroxol Hydrochloride | [1] Ambroxol Ambroxol | [1] Ambroxol
Ambroxol
💬 | - | - | [2] 6 6, 19 💬 |
77 | AMBROXOL HYDROCHLORIDE PH. EUR. | [1] Ambroxol Ambroxol | [1] Ambroxol
Ambroxol
💬 | - | - | [1] 19 19 💬 |
78 | Angiotensin | [1] Angiotensin II Angiotensin II | [2] Angiotensin II
Angiotensin II
,
Angiotensin II
💬 | [2] AGTR1 AGTR1, AGTR2 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [7] 17 17, 19, 46, 66, 86, 222, 224 💬 |
79 | ARIMOCLOMOL | [1] Arimoclomol Arimoclomol | [1] Arimoclomol
Arimoclomol
💬 | - | - | [3] 2 2, 15, 19 💬 |
80 | Arimoclomol (hard gelatine capsule) | [2] Arimoclomol Arimoclomol, Gelatin | [3] Gelatin
Gelatin
,
Donkey glue
,
Arimoclomol
💬 | - | - | [1] 19 19 💬 |
81 | Arimoclomol (HPMC capsule) | [1] Arimoclomol Arimoclomol | [1] Arimoclomol
Arimoclomol
💬 | - | - | [1] 19 19 💬 |
82 | Arimoclomol citrate | [1] Arimoclomol Arimoclomol | [1] Arimoclomol
Arimoclomol
💬 | - | - | [2] 15 15, 19 💬 |
83 | Arylsulfatase A | - | - | - | - | [1] 19 19 💬 |
84 | AT-GTX-501 | - | - | - | - | [1] 19 19 💬 |
85 | AT1001 | - | - | - | - | [1] 19 19 💬 |
86 | AT1001 150 mg | - | - | - | - | [1] 19 19 💬 |
87 | AT2101 | - | - | - | - | [1] 19 19 💬 |
88 | ATALUREN | [1] Ataluren Ataluren | [1] Ataluren
Ataluren
💬 | - | - | [6] 19 19, 113, 140, 246, 299, 329 💬 |
89 | AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING THE HUMAN SGSH GENE | - | - | - | - | [1] 19 19 💬 |
90 | Autologous CD34+ cells transduced with a lentiviral vector encoding the ARSA cDNA | - | - | - | - | [1] 19 19 💬 |
91 | Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII | - | - | - | - | [1] 19 19 💬 |
92 | Autologous Plasmablasts | - | - | - | - | [1] 19 19 💬 |
93 | Autologous Plasmablasts (B cells) | - | - | - | - | [1] 19 19 💬 |
94 | AVR-RD-01 | - | - | - | - | [1] 19 19 💬 |
95 | AVR-RD-02 | - | - | - | - | [1] 19 19 💬 |
96 | AX | - | - | - | - | [1] 19 19 💬 |
97 | AX 250 | - | - | - | - | [1] 19 19 💬 |
98 | AXO-AAV-GM2 High Dose | - | - | - | - | [1] 19 19 💬 |
99 | AXO-AAV-GM2 Low Dose | - | - | - | - | [1] 19 19 💬 |
100 | AXO-AAV-GM2 Middle Dose | - | - | - | - | [1] 19 19 💬 |
101 | AXO-AAV-GM2 Starting Dose | - | - | - | - | [1] 19 19 💬 |
102 | Azathioprine | [1] Azathioprine Azathioprine | [1] Azathioprine
Azathioprine
💬 | - | - | [21] 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162 💬 |
103 | Azathioprine (AZA) | [1] Azathioprine Azathioprine | [1] Azathioprine
Azathioprine
💬 | - | - | [3] 13 13, 19, 97 💬 |
104 | B (migalastat) | [1] Migalastat Migalastat | [1] Migalastat
Migalastat
💬 | - | - | [1] 19 19 💬 |
105 | Beta-cyclodextrin | [1] Betadex Betadex | [1] Betadex
Betadex
💬 | - | - | [1] 19 19 💬 |
106 | Beta-Galactosidase | [1] Tilactase Tilactase | [1] Lactase
Lactase
💬 | - | - | [1] 19 19 💬 |
107 | Beta-Mercaptoethylamine | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
108 | Beta-mercaptoethylamine Hydrochloride & 2-aminoethanethiol Hydrochloride | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
109 | BHP001 | - | - | - | - | [1] 19 19 💬 |
110 | Blood sampling for biological and genetic analysis | - | - | - | - | [1] 19 19 💬 |
111 | BM110 | - | - | - | - | [1] 19 19 💬 |
112 | BMN 110 | - | - | - | - | [1] 19 19 💬 |
113 | BMN 110 - Every Other Week | - | - | - | - | [1] 19 19 💬 |
114 | BMN 110 - Weekly | - | - | - | - | [1] 19 19 💬 |
115 | BMN 110 Every Other Week | - | - | - | - | [1] 19 19 💬 |
116 | BMN 110 Weekly | - | - | - | - | [1] 19 19 💬 |
117 | BMN 190 | - | - | - | - | [1] 19 19 💬 |
118 | BMN 250 | - | - | - | - | [1] 19 19 💬 |
119 | BMN190 recombinant human tripeptidyl peptidase-1 (rhTPP1) | - | - | - | - | [1] 19 19 💬 |
120 | Brineura | [1] Cerliponase alfa Cerliponase alfa | [1] Cerliponase alfa
Cerliponase alfa
💬 | [1] TPP1 TPP1 💬 | [1] Lysosome Lysosome 💬 | [1] 19 19 💬 |
121 | BUSILVEX | [1] Busulfan Busulfan | [1] Busulfan
Busulfan
💬 | - | - | [4] 19 19, 36, 60, 65 💬 |
122 | BUSILVEX - 6 MG/ML - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO - 10 ML 8 FLACONCINI | [1] Busulfan Busulfan | [1] Busulfan
Busulfan
💬 | - | - | [2] 19 19, 65 💬 |
123 | Busulfan | [1] Busulfan Busulfan | [1] Busulfan
Busulfan
💬 | - | - | [13] 19 19, 20, 28, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 💬 |
124 | Busulfan, Cyclophosphamide, Antithymocyte Globulin | [2] Busulfan Busulfan, Cyclophosphamide | [3] Busulfan
Busulfan
,
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [2] 19 19, 20 💬 |
125 | Busulfan, Cyclophosphamide, ATG | [2] Busulfan Busulfan, Cyclophosphamide | [3] Busulfan
Busulfan
,
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [1] 19 19 💬 |
126 | BUSULFANO | [1] Busulfan Busulfan | [1] Busulfan
Busulfan
💬 | - | - | [1] 19 19 💬 |
127 | C (migalastat) | [1] Migalastat Migalastat | [1] Migalastat
Migalastat
💬 | - | - | [1] 19 19 💬 |
128 | Calcium | [2] Calcium Calcium, Calcium carbonate | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬 | - | - | [27] 6 6, 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 156, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
129 | Calcium carbonate | [3] Calcium Calcium, Calcium carbonate, Carbonate ion | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬 | - | - | [8] 13 13, 19, 46, 53, 75, 96, 235, 299 💬 |
130 | CALD HR-D (High-Risk, Regimen C) | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬 |
131 | CALD HR-D (High-Risk, Regimen D) | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬 |
132 | CALD SR-A (Standard-Risk, Regimen A) | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬 |
133 | CALD SR-B (Standard-Risk, Regimen B) | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬 |
134 | Campath | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬 | [1] CD52 CD52 💬 | - | [12] 19 19, 20, 49, 51, 60, 62, 65, 164, 234, 283, 285, 326 💬 |
135 | Campath-1H | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬 | [1] CD52 CD52 💬 | - | [6] 19 19, 20, 60, 234, 285, 326 💬 |
136 | Cannabis | [1] Medical Cannabis Medical Cannabis | - | - | - | [7] 2 2, 6, 13, 19, 90, 96, 97 💬 |
137 | Cannabis sativa L., folium cum flore | [1] Medical Cannabis Medical Cannabis | - | - | - | [1] 19 19 💬 |
138 | Carbonate | [1] Carbonate ion Carbonate ion | - | - | - | [12] 2 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬 |
139 | Cellule CD34+ autologhe trasdotte con IDUA LV codificante per il cDNA dell'alfa-L-iduronidasi | - | - | - | - | [1] 19 19 💬 |
140 | Cerdelga | [1] Eliglustat Eliglustat | [1] Eliglustat
Eliglustat
💬 | [1] UGCG UGCG 💬 | [2] Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
141 | Ceredase | [1] Alglucerase Alglucerase | [1] Alglucerase
Alglucerase
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
142 | CEREDASE™ | [1] Alglucerase Alglucerase | [1] Alglucerase
Alglucerase
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
143 | CEREZYME | [1] Imiglucerase Imiglucerase | [1] Imiglucerase
Imiglucerase
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
144 | Cerezyme (imiglucerase for injection) | [1] Imiglucerase Imiglucerase | [1] Imiglucerase
Imiglucerase
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
145 | Cerezyme 400 Units Powder for concentrate for solution for infusion | [1] Imiglucerase Imiglucerase | [1] Imiglucerase
Imiglucerase
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
146 | Cerezyme® | [1] Imiglucerase Imiglucerase | [1] Imiglucerase
Imiglucerase
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
147 | Cerezyme® / Imiglucerase | [1] Imiglucerase Imiglucerase | [1] Imiglucerase
Imiglucerase
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
148 | Cerliponase Alfa | [1] Cerliponase alfa Cerliponase alfa | [1] Cerliponase alfa
Cerliponase alfa
💬 | [1] TPP1 TPP1 💬 | [1] Lysosome Lysosome 💬 | [1] 19 19 💬 |
149 | CHEMICALLY MODIFIED RECOMBINANT HUMAN SULFAMIDASE | - | - | - | - | [1] 19 19 💬 |
150 | CHF6657 | - | - | - | - | [1] 19 19 💬 |
151 | CHOLECALCIFEROL | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [9] 13 13, 19, 34, 46, 49, 96, 97, 298, 299 💬 |
152 | Cholesterol | [1] Cholesterol Cholesterol | [1] Cholesterol
Cholesterol
💬 | - | - | [6] 8 8, 19, 90, 160, 222, 310 💬 |
153 | Clofarabine | [1] Clofarabine Clofarabine | [1] Clofarabine
Clofarabine
💬 | [3] POLA1 POLA1, POLA2, RRM1 💬 | [7] DNA replication DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [5] 19 19, 20, 60, 234, 326 💬 |
154 | Coversyl | [1] Perindopril Perindopril | [1] Perindopril
Perindopril
💬 | [1] ACE ACE 💬 | [6] Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [2] 19 19, 167 💬 |
155 | Coversyl PLUS | - | - | - | - | [1] 19 19 💬 |
156 | CRYOPRESERVED AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING HUMAN SGSH GENE | - | - | - | - | [1] 19 19 💬 |
157 | CsA | - | - | - | - | [8] 19 19, 49, 50, 53, 60, 63, 222, 228 💬 |
158 | CTNS-RD-04 or CTNS-RD-04-LB (where the suffix -LB stands for LentiBOOST) | - | - | - | - | [1] 19 19 💬 |
159 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [44] 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 💬 |
160 | Cyclosporine | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [37] 11 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 107, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
161 | Cyclosporine A | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [11] 19 19, 20, 36, 49, 50, 53, 58, 60, 107, 234, 283 💬 |
162 | Cyclosporine A (CsA) | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 19 19, 60 💬 |
163 | Cystadane | [1] Betaine Betaine | [1] Betaine
Betaine
💬 | - | - | [1] 19 19 💬 |
164 | Cystadane anhydrous | [1] Betaine Betaine | [1] Betaine
Betaine
💬 | - | - | [1] 19 19 💬 |
165 | CYSTADROPS | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
166 | CYSTADROPS 0.55% eye drops, solution | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
167 | CYSTAGON | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [3] 8 8, 19, 299 💬 |
168 | Cystagon 150mg | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
169 | Cystagon 50mg | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
170 | Cystagon® | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
171 | Cystagon® (Cysteamine Bitartrate) | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
172 | Cysteamine | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [4] 8 8, 19, 21, 299 💬 |
173 | Cysteamine (mercaptamine) viscous solution | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
174 | Cysteamine Bitartrate | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [4] 8 8, 19, 21, 299 💬 |
175 | Cysteamine bitartrate (INN: mercaptamine bitartrate | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
176 | Cysteamine bitartrate (INN: mercaptamine bitartrate ) | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
177 | Cysteamine bitartrate (INN: mercaptamine bitartrate) | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
178 | Cysteamine Bitartrate Delayed-release Capsules | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
179 | Cysteamine Bitartrate Delayed-release Capsules (RP103) | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
180 | CYSTEAMINE HYDROCHLORIDE | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
181 | Cysteine | [1] Cysteine Cysteine | - | - | - | [10] 13 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬 |
182 | D (migalastat) | [1] Migalastat Migalastat | [1] Migalastat
Migalastat
💬 | - | - | [1] 19 19 💬 |
183 | Dapagliflozin | [1] Dapagliflozin Dapagliflozin | [1] Dapagliflozin
Dapagliflozin
💬 | [1] SLC5A2 SLC5A2 💬 | - | [7] 19 19, 49, 66, 67, 86, 88, 222 💬 |
184 | Dapagliflozin 10mg Tab | [1] Dapagliflozin Dapagliflozin | [1] Dapagliflozin
Dapagliflozin
💬 | [1] SLC5A2 SLC5A2 💬 | - | [1] 19 19 💬 |
185 | Diagnosis of Fabry disease | - | - | - | - | [1] 19 19 💬 |
186 | DIFENIDRAMINA CLORIDRATO | - | - | - | - | [3] 11 11, 19, 63 💬 |
187 | DNL310 | - | - | - | - | [1] 19 19 💬 |
188 | DNL310 Drug Substance | - | - | - | - | [1] 19 19 💬 |
189 | Dried blood spot (DBS) sampling | - | - | - | - | [1] 19 19 💬 |
190 | DRX005B | - | - | - | - | [1] 19 19 💬 |
191 | DUOC-01 | - | - | - | - | [3] 13 13, 19, 20 💬 |
192 | E (migalastat) | [1] Migalastat Migalastat | [1] Migalastat
Migalastat
💬 | - | - | [1] 19 19 💬 |
193 | Elaprase | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬 | [1] IDS IDS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
194 | Elaprase 2mg/ml | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬 | [1] IDS IDS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
195 | Elaprase for intravenous (IV) infusion | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬 | [1] IDS IDS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
196 | Elaprase_0.5mg/kg | - | - | - | - | [1] 19 19 💬 |
197 | Elelyso | [1] Taliglucerase alfa Taliglucerase alfa | [1] Taliglucerase alfa
Taliglucerase alfa
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
198 | Elelyso 60 units/kg | [1] Taliglucerase alfa Taliglucerase alfa | [1] Taliglucerase alfa
Taliglucerase alfa
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
199 | Eliglustat | [1] Eliglustat Eliglustat | [1] Eliglustat
Eliglustat
💬 | [1] UGCG UGCG 💬 | [2] Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
200 | ELIGLUSTAT TARTRATE | [1] Eliglustat Eliglustat | [1] Eliglustat
Eliglustat
💬 | [1] UGCG UGCG 💬 | [2] Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
201 | Eliglustat Tartrate – Powder for Oral Suspension | [1] Eliglustat Eliglustat | [1] Eliglustat
Eliglustat
💬 | [1] UGCG UGCG 💬 | [2] Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
202 | Elosulfase alfa | [1] Elosulfase alfa Elosulfase alfa | [1] Elosulfase alfa
Elosulfase alfa
💬 | [1] GALNS GALNS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
203 | Elosulfase Alfa 1 MG/ML Intravenous Solution [VIMIZIM] | [1] Elosulfase alfa Elosulfase alfa | [1] Elosulfase alfa
Elosulfase alfa
💬 | [1] GALNS GALNS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
204 | ELX-02 | [1] ELX-02 ELX-02 | - | - | - | [3] 19 19, 218, 299 💬 |
205 | Enalapril | [1] Enalapril Enalapril | [1] Enalapril
Enalapril
💬 | [1] ACE ACE 💬 | [6] Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [6] 19 19, 46, 66, 113, 210, 222 💬 |
206 | Enalapril and other angiotensin converting enzyme inhibitors | [2] Angiotensin II Angiotensin II, Enalapril | [3] Angiotensin II
Angiotensin II
,
Angiotensin II
,
Enalapril
💬 | [3] ACE ACE, AGTR1, AGTR2 💬 | [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 19 19 💬 |
207 | Enriched Hematopoetic Stem Cell Infusion | - | - | - | - | [2] 19 19, 284 💬 |
208 | Enzyme replacement | - | - | - | - | [1] 19 19 💬 |
209 | Enzyme replacement therapy | - | - | - | - | [1] 19 19 💬 |
210 | Enzyme replacement therapy (Agalsidase alpha (Replagal®)) | [1] Agalsidase alfa Agalsidase alfa | [1] Agalsidase alfa
Agalsidase alfa
💬 | [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
211 | Enzyme replacement therapy (ERT) | - | - | - | - | [1] 19 19 💬 |
212 | ERT | - | - | - | - | [1] 19 19 💬 |
213 | EU-sourced Cerezyme | [1] Imiglucerase Imiglucerase | [1] Imiglucerase
Imiglucerase
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
214 | FABRAZYME | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬 | [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
215 | Fabrazyme (agalsidase beta) | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬 | [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
216 | Fabrazyme (agalsidase beta) 1 mg/kg | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬 | [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
217 | FABRAZYME - 35 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE ENDOVENOSA 1 FLACONCINO | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬 | [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
218 | Fabrazyme 35 mg | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬 | [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
219 | Fabrazyme 5 mg | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬 | [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
220 | FBX-101 | - | - | - | - | [1] 19 19 💬 |
221 | FLT190 | - | - | - | - | [1] 19 19 💬 |
222 | FLT201 | - | - | - | - | [1] 19 19 💬 |
223 | Fludarabina | [1] Fludarabine Fludarabine | [1] Fludarabine
Fludarabine
💬 | [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [2] 19 19, 65 💬 |
224 | FLUDARABINA ACCORD - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 5 FLACONCINI IN VETRO DA 2 ML | [1] Fludarabine Fludarabine | [1] Fludarabine
Fludarabine
💬 | [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 19 19 💬 |
225 | FLUDARABINA FOSFATO | [1] Fludarabine Fludarabine | [1] Fludarabine
Fludarabine
💬 | [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 19 19 💬 |
226 | Frozen autologous CD34+ hematopoietic stem and progenitor cells genetically modified with the lentiviral vector IDUA LV, encoding for the a-L-iduronidase cDNA, in their final formulation medium. | - | - | - | - | [1] 19 19 💬 |
227 | GA-GCB | [1] Velaglucerase alfa Velaglucerase alfa | [1] Velaglucerase alfa
Velaglucerase alfa
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
228 | GA-GCB (velaglucerase alfa) | [1] Velaglucerase alfa Velaglucerase alfa | [1] Velaglucerase alfa
Velaglucerase alfa
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
229 | GABAPENTIN | [1] Gabapentin Gabapentin | [1] Gabapentin
Gabapentin
💬 | [5] CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | [5] 6 6, 13, 19, 70, 298 💬 |
230 | Galafold | [1] Migalastat Migalastat | [1] Migalastat
Migalastat
💬 | - | - | [1] 19 19 💬 |
231 | GALSULFASE | [1] Galsulfase Galsulfase | [1] Galsulfase
Galsulfase
💬 | [1] ARSB ARSB 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
232 | GC1111_0.5mg/kg | - | - | - | - | [1] 19 19 💬 |
233 | GC1111_1.0mg/kg | - | - | - | - | [1] 19 19 💬 |
234 | GC1119 | - | - | - | - | [1] 19 19 💬 |
235 | GC1123 | - | - | - | - | [1] 19 19 💬 |
236 | Gelatine | [1] Gelatin Gelatin | [2] Gelatin
Gelatin
,
Donkey glue
💬 | - | - | [1] 19 19 💬 |
237 | Gene Activated a-Galactosidase A | - | - | - | - | [1] 19 19 💬 |
238 | Gene Activated Human Glucocerebrosidase | - | - | - | - | [1] 19 19 💬 |
239 | Gene activated human glucocerebrosidase, velaglucerase alfa | [1] Velaglucerase alfa Velaglucerase alfa | [1] Velaglucerase alfa
Velaglucerase alfa
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
240 | Gene-Activated Human Glucocerebrosidase | - | - | - | - | [1] 19 19 💬 |
241 | Gene-Activated Human Glucocerebrosidase 200U/vial | - | - | - | - | [1] 19 19 💬 |
242 | Gene-Activated Human Glucocerebrosidase 400U/vial | - | - | - | - | [1] 19 19 💬 |
243 | Genetic analyses | - | - | - | - | [1] 19 19 💬 |
244 | Genetic HMI-203 | - | - | - | - | [1] 19 19 💬 |
245 | GENISTEIN | [1] Genistein Genistein | [1] Genistein
Genistein
💬 | - | - | [2] 19 19, 299 💬 |
246 | Genistein aglycone | [1] Genistein Genistein | [1] Genistein
Genistein
💬 | - | - | [1] 19 19 💬 |
247 | Genz-112638 | - | - | - | - | [1] 19 19 💬 |
248 | GENZ-682452 | [1] Venglustat Venglustat | [1] Venglustat
Venglustat
💬 | [1] UGCG UGCG 💬 | [2] Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [3] 6 6, 19, 67 💬 |
249 | Genz-682452-AA | [1] Venglustat Venglustat | [1] Venglustat
Venglustat
💬 | [1] UGCG UGCG 💬 | [2] Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
250 | Genz-682452-AU | [1] Venglustat Venglustat | [1] Venglustat
Venglustat
💬 | [1] UGCG UGCG 💬 | [2] Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [3] 6 6, 19, 67 💬 |
251 | GLA | - | - | - | - | [2] 13 13, 19 💬 |
252 | GLA gene | - | - | - | - | [1] 19 19 💬 |
253 | GLA genetic sequencing. | - | - | - | - | [1] 19 19 💬 |
254 | GLUCOCEREBROSIDASE | - | - | - | - | [1] 19 19 💬 |
255 | GLUCOCEREBROSIDASE UMANO GENE-ATTIVATO | - | - | - | - | [1] 19 19 💬 |
256 | GNR-055 | - | - | - | - | [1] 19 19 💬 |
257 | GNR-055 1.0-2.0-3.0 mg/kg | - | - | - | - | [1] 19 19 💬 |
258 | GNR-055 2.0 mg/kg | - | - | - | - | [1] 19 19 💬 |
259 | GNR-055 3.0 mg/kg | - | - | - | - | [1] 19 19 💬 |
260 | GR181413 | - | - | - | - | [1] 19 19 💬 |
261 | GR181413A | - | - | - | - | [1] 19 19 💬 |
262 | GR181413A/AT1001 capsule | - | - | - | - | [1] 19 19 💬 |
263 | GR181413A/AT1001 solution | - | - | - | - | [1] 19 19 💬 |
264 | Growth hormone | [1] Somatotropin Somatotropin | - | - | - | [14] 2 2, 13, 19, 46, 78, 96, 107, 187, 191, 193, 195, 265, 276, 299 💬 |
265 | GSK2788723 | - | - | - | - | [1] 19 19 💬 |
266 | GZ/SAR402671 | - | - | - | - | [2] 19 19, 67 💬 |
267 | GZ385660 | - | - | - | - | [1] 19 19 💬 |
268 | GZ402665 | - | - | - | - | [1] 19 19 💬 |
269 | GZ402671 | - | - | - | - | [2] 19 19, 67 💬 |
270 | GZ402671 / SAR402671 | - | - | - | - | [1] 19 19 💬 |
271 | Hematopoetic Stem Cell Transplantation | - | - | - | - | [5] 19 19, 65, 120, 160, 326 💬 |
272 | Hematopoietic stem cell infusion | - | - | - | - | [2] 19 19, 20 💬 |
273 | Hematopoietic Stem Cell Transplantation | - | - | - | - | [12] 11 11, 13, 14, 19, 20, 35, 46, 49, 51, 96, 234, 285 💬 |
274 | Heparán N sulfatasa humana recombinante | - | - | - | - | [1] 19 19 💬 |
275 | Heparán N sulfatasa humana recombinante (rhHNS) | - | - | - | - | [1] 19 19 💬 |
276 | HGT-1110 | - | - | - | - | [1] 19 19 💬 |
277 | HGT-1111 | - | - | - | - | [1] 19 19 💬 |
278 | HGT-1410 | - | - | - | - | [1] 19 19 💬 |
279 | HGT-2310 | - | - | - | - | [1] 19 19 💬 |
280 | HIDS DONOR | - | - | - | - | [1] 19 19 💬 |
281 | HuCNS-SC | - | - | - | - | [1] 19 19 💬 |
282 | Human Glucocerebrosidase (prGCD) | [1] Taliglucerase alfa Taliglucerase alfa | [1] Taliglucerase alfa
Taliglucerase alfa
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
283 | Human glucocerebrosidase cDNA | - | - | - | - | [1] 19 19 💬 |
284 | Human glucocerebrosidase gene into autologous peripheral blood stem cells | - | - | - | - | [1] 19 19 💬 |
285 | Human Placental Derived Stem Cell | - | - | - | - | [4] 19 19, 20, 60, 284 💬 |
286 | Hunterase | [1] Idursulfase beta Idursulfase beta | [1] Idursulfase beta
Idursulfase beta
💬 | [1] IDS IDS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
287 | Hydroxypropyl-beta-cyclodextrin | [1] Betadex Betadex | [1] Betadex
Betadex
💬 | - | - | [1] 19 19 💬 |
288 | Hydroxypropyl-ß-cyclodextrin | - | - | - | - | [1] 19 19 💬 |
289 | Hydroxyurea | [1] Hydroxyurea Hydroxyurea | [1] Hydroxyurea
Hydroxyurea
💬 | [1] RRM2 RRM2 💬 | [7] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬 | [8] 3 3, 13, 19, 20, 65, 85, 86, 284 💬 |
290 | I2S | - | - | - | - | [1] 19 19 💬 |
291 | I2S-IT | - | - | - | - | [1] 19 19 💬 |
292 | IB1001 | - | - | - | - | [2] 19 19, 65 💬 |
293 | Iduronate 2-sulfatase | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬 | [1] IDS IDS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
294 | Iduronate-2-sulfatase enzyme replacement therapy | - | - | - | - | [1] 19 19 💬 |
295 | IDURONATE-2-SULFATASE FUSED TO A FC POLYPEPTIDE THAT BINDS TO THE HUMAN TRANSFERRIN RECEPTOR | - | - | - | - | [1] 19 19 💬 |
296 | IDURSULFASA | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬 | [1] IDS IDS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
297 | IDURSULFASE | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬 | [1] IDS IDS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
298 | Idursulfase (ELAPRASE) | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬 | [1] IDS IDS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
299 | Idursulfase (I2S) | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬 | [1] IDS IDS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
300 | Idursulfase (I2S)-IT | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬 | [1] IDS IDS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
301 | Idursulfase beta | [2] Idursulfase Idursulfase, Idursulfase beta | [2] Idursulfase
Idursulfase
,
Idursulfase beta
💬 | [1] IDS IDS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
302 | Idursulfase IT (1 mg) | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬 | [1] IDS IDS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
303 | Idursulfase IT (10 mg) | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬 | [1] IDS IDS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
304 | Idursulfase IT (30 mg) | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬 | [1] IDS IDS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
305 | Idursulfase(12S)-IT | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬 | [1] IDS IDS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
306 | Idursulfase(I2S)-IT | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬 | [1] IDS IDS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
307 | Idursulfase-IT | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬 | [1] IDS IDS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
308 | IGF2 | - | - | - | - | [1] 19 19 💬 |
309 | IMD | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬 |
310 | IMD Preparative Regimen | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬 |
311 | IMIGLUCERASA | [1] Imiglucerase Imiglucerase | [1] Imiglucerase
Imiglucerase
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
312 | IMIGLUCERASE | [1] Imiglucerase Imiglucerase | [1] Imiglucerase
Imiglucerase
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
313 | Imiglucerasi | - | - | - | - | [1] 19 19 💬 |
314 | Imiglucérase (drug) pharmacokinetics | - | - | - | - | [1] 19 19 💬 |
315 | Inactive Reminder Capsules | - | - | - | - | [1] 19 19 💬 |
316 | Inactive Reminder Product | - | - | - | - | [1] 19 19 💬 |
317 | INN Not available | - | - | - | - | [2] 19 19, 46 💬 |
318 | INNOZIDE | - | - | - | - | [1] 19 19 💬 |
319 | Intracerebral administration of AAVrh.10cuARSA | - | - | - | - | [1] 19 19 💬 |
320 | Intrathecal recombinant human alpha iduronidase | - | - | - | - | [1] 19 19 💬 |
321 | Iohexol | [1] Iohexol Iohexol | [1] Iohexol
Iohexol
💬 | - | - | [2] 19 19, 67 💬 |
322 | IRT Laronidase | [1] Laronidase Laronidase | [1] Laronidase
Laronidase
💬 | [1] IDUA IDUA 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
323 | Isofagamine tartrate | - | - | - | - | [1] 19 19 💬 |
324 | ISU302 | - | - | - | - | [1] 19 19 💬 |
325 | IV migalastat HCl | [1] Migalastat Migalastat | [1] Migalastat
Migalastat
💬 | - | - | [1] 19 19 💬 |
326 | IVA 336 | - | - | - | - | [1] 19 19 💬 |
327 | JR-141 | - | - | - | - | [1] 19 19 💬 |
328 | JR-141 or Idursulfase | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬 | [1] IDS IDS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
329 | JR-171 (lepunafusp alfa) | - | - | - | - | [1] 19 19 💬 |
330 | KANUMA | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬 | [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 💬 |
331 | LAMAZYM | [1] Velmanase alfa Velmanase alfa | [1] Velmanase alfa
Velmanase alfa
💬 | [1] MAN2B1 MAN2B1 💬 | [2] Lysosome Lysosome, Other glycan degradation 💬 | [1] 19 19 💬 |
332 | LARONIDASE | [1] Laronidase Laronidase | [1] Laronidase
Laronidase
💬 | [1] IDUA IDUA 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [2] 19 19, 256 💬 |
333 | Laronidase ERT | [1] Laronidase Laronidase | [1] Laronidase
Laronidase
💬 | [1] IDUA IDUA 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
334 | Laronidase therapy and a stem cell transplant | [1] Laronidase Laronidase | [1] Laronidase
Laronidase
💬 | [1] IDUA IDUA 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
335 | Ledipasvir | [1] Ledipasvir Ledipasvir | [1] Ledipasvir
Ledipasvir
💬 | - | - | [1] 19 19 💬 |
336 | Ledipasvir/Sofosbuvir | [2] Ledipasvir Ledipasvir, Sofosbuvir | [2] Sofosbuvir
Sofosbuvir
,
Ledipasvir
💬 | - | - | [1] 19 19 💬 |
337 | Lenograstim | [1] Lenograstim Lenograstim | [1] Lenograstim
Lenograstim
💬 | [1] CSF3R CSF3R 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [7] 2 2, 13, 16, 18, 19, 57, 65 💬 |
338 | Lentivirus Alpha-gal A transduced stem cells | - | - | - | - | [1] 19 19 💬 |
339 | Lentivirus-mediated delivery of ARSA to the CNS. | - | - | - | - | [1] 19 19 💬 |
340 | Leucine | [1] Leucine Leucine | [1] Leucine
Leucine
💬 | - | - | [6] 6 6, 19, 65, 283, 284, 299 💬 |
341 | Leucovorin | [1] Leucovorin Leucovorin | [2] Folinic acid
Folinic acid
,
Folinic acid calcium salt pentahydrate
💬 | - | - | [2] 19 19, 46 💬 |
342 | Lipasa ácida lisosómica, esterasa, colesterol (gen humano LIPA), lipasa ácida lisosómica (gen humano LIPA) | - | - | - | - | [1] 19 19 💬 |
343 | Lisinopril | [1] Lisinopril Lisinopril | [2] Lisinopril
Lisinopril
,
Lisinopril
💬 | [1] ACE ACE 💬 | [6] Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [7] 19 19, 46, 49, 66, 67, 113, 222 💬 |
344 | Lopace | - | - | - | - | [1] 19 19 💬 |
345 | Losartan | [1] Losartan Losartan | [1] Losartan
Losartan
💬 | [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [17] 17 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
346 | Losartan and other angiotensin receptor blockers | [2] Angiotensin II Angiotensin II, Losartan | [3] Angiotensin II
Angiotensin II
,
Angiotensin II
,
Losartan
💬 | [2] AGTR1 AGTR1, AGTR2 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 19 19 💬 |
347 | Lucerastat | [1] Lucerastat Lucerastat | [1] Lucerastat
Lucerastat
💬 | [1] UGCG UGCG 💬 | [2] Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
348 | LY3884961 | [1] LY3884961 LY3884961 | - | - | - | [1] 19 19 💬 |
349 | Lymphocyte gene therapy | - | - | - | - | [1] 19 19 💬 |
350 | LYS | - | - | - | - | [1] 19 19 💬 |
351 | LYS-GM101 | - | - | - | - | [1] 19 19 💬 |
352 | LYS-SAF302 | - | - | - | - | [1] 19 19 💬 |
353 | Lysodase | - | - | - | - | [1] 19 19 💬 |
354 | Lysosomal acid lipase, Esterase cholesterol (human gene LIPA), Lysosomal acid lipase (human gene LIPA) | [1] Cholesterol Cholesterol | [1] Cholesterol
Cholesterol
💬 | - | - | [1] 19 19 💬 |
355 | Lysosomal acid lipase, Esterase, cholesterol (human gene LIPA), Lysosomal acid lipase (human gene LIPA) | [1] Cholesterol Cholesterol | [1] Cholesterol
Cholesterol
💬 | - | - | [1] 19 19 💬 |
356 | MabThera | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬 | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [22] 11 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬 |
357 | MABTHERA - 2 FIALE 100 MG 10 ML | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬 | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2] 19 19, 65 💬 |
358 | Medication to suppress the immune system | - | - | - | - | [1] 19 19 💬 |
359 | Melphalan | [1] Melphalan Melphalan | [1] Melphalan
Melphalan
💬 | - | - | [15] 11 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬 |
360 | Mepsevii | [1] Vestronidase alfa Vestronidase alfa | [1] Vestronidase alfa
Vestronidase alfa
💬 | [1] GUSB GUSB 💬 | [8] Ascorbate and aldarate metabolism Ascorbate and aldarate metabolism, Biosynthesis of cofactors, Drug metabolism - other enzymes, Glycosaminoglycan degradation, Lysosome, Metabolic pathways, Pentose and glucuronate interconversions, Porphyrin metabolism 💬 | [1] 19 19 💬 |
361 | Mercaptamina | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
362 | Mercaptamine | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
363 | MERCAPTAMINE BITARTRATE | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
364 | MERCAPTAMINE HYDROCHLORIDE | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
365 | Mercaptamine, mercamine, 2-aminoethanethiol | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
366 | Metazym | - | - | - | - | [1] 19 19 💬 |
367 | Methotrexate | [1] Methotrexate Methotrexate | [1] Methotrexate
Methotrexate
💬 | [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [38] 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬 |
368 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [1] Methylprednisolone
Methylprednisolone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [46] 2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
369 | MIGALASTAT | [1] Migalastat Migalastat | [1] Migalastat
Migalastat
💬 | - | - | [1] 19 19 💬 |
370 | Migalastat HCl | [1] Migalastat Migalastat | [1] Migalastat
Migalastat
💬 | - | - | [1] 19 19 💬 |
371 | Migalastat HCl 150 mg | [1] Migalastat Migalastat | [1] Migalastat
Migalastat
💬 | - | - | [1] 19 19 💬 |
372 | MIGALASTAT HYDROCHLORIDE | [1] Migalastat Migalastat | [1] Migalastat
Migalastat
💬 | - | - | [1] 19 19 💬 |
373 | Migalastat hydrocloride | [1] Migalastat Migalastat | [1] Migalastat
Migalastat
💬 | - | - | [1] 19 19 💬 |
374 | MIGLUSTAT | [1] Miglustat Miglustat | [1] Miglustat
Miglustat
💬 | [1] UGCG UGCG 💬 | [2] Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [3] 19 19, 256, 299 💬 |
375 | MIGLUSTAT (ZAVESCA) | [1] Miglustat Miglustat | [1] Miglustat
Miglustat
💬 | [1] UGCG UGCG 💬 | [2] Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
376 | Moss-aGal (recombinant human alpha-galactosidase A produced in moss) | [1] Agalsidase alfa Agalsidase alfa | [1] Agalsidase alfa
Agalsidase alfa
💬 | [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
377 | Mozobil | [1] Plerixafor Plerixafor | [1] Plerixafor
Plerixafor
💬 | [1] CXCR4 CXCR4 💬 | [14] Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | [3] 19 19, 65, 285 💬 |
378 | MOZOBIL - 20 MG/ML - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - F | [1] Plerixafor Plerixafor | [1] Plerixafor
Plerixafor
💬 | [1] CXCR4 CXCR4 💬 | [14] Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | [1] 19 19 💬 |
379 | Mucoangin | - | - | - | - | [1] 19 19 💬 |
380 | Mycophenolate | [1] Mycophenolic acid Mycophenolic acid | [1] Mycophenolic acid
Mycophenolic acid
💬 | [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [36] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
381 | Mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [2] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolic acid
💬 | [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [34] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
382 | Mycophenylate mofetil | - | - | - | - | [2] 19 19, 20 💬 |
383 | MYELOSTIM - 34 1 FLACONCINO LIOFILIZZATO 33.6 MIU + SIRINGA PRERIEMPITA SOLVENTE 1 ML | - | - | - | - | [2] 19 19, 65 💬 |
384 | N acetyl cysteine | [1] Cysteine Cysteine | - | - | - | [1] 19 19 💬 |
385 | N Acetyl L Leucine | [1] Leucine Leucine | [1] Leucine
Leucine
💬 | - | - | [1] 19 19 💬 |
386 | N-Acetyl-L Leucine | [1] Leucine Leucine | [1] Leucine
Leucine
💬 | - | - | [1] 19 19 💬 |
387 | N-Acetyl-L-Leucine | [2] L-Acetylleucine L-Acetylleucine, Leucine | [1] Leucine
Leucine
💬 | - | - | [2] 19 19, 65 💬 |
388 | N-Acetylcysteine | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬 | - | - | [13] 6 6, 13, 19, 20, 21, 49, 58, 85, 90, 111, 164, 299, 337 💬 |
389 | N-acetylgalactosamine 4-sulfatase | - | - | - | - | [1] 19 19 💬 |
390 | Naglazyme | [1] Galsulfase Galsulfase | [1] Galsulfase
Galsulfase
💬 | [1] ARSB ARSB 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
391 | Naglazyme (galsulfase) | [1] Galsulfase Galsulfase | [1] Galsulfase
Galsulfase
💬 | [1] ARSB ARSB 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
392 | Naglazyme® | [1] Galsulfase Galsulfase | [1] Galsulfase
Galsulfase
💬 | [1] ARSB ARSB 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
393 | NGN-101 | - | - | - | - | [1] 19 19 💬 |
394 | Non applicable | - | - | - | - | [2] 10 10, 19 💬 |
395 | Odiparcil | [1] Odiparcil Odiparcil | - | - | - | [1] 19 19 💬 |
396 | OGT 918 | - | - | - | - | [2] 19 19, 299 💬 |
397 | OGT918 | - | - | - | - | [1] 19 19 💬 |
398 | OGT923 | - | - | - | - | [1] 19 19 💬 |
399 | OLENASUFLIGENE RELDUPARVOVEC | [1] Olenasufligene relduparvovec Olenasufligene relduparvovec | - | - | - | [1] 19 19 💬 |
400 | OLIPUDASE ALFA | [1] Olipudase alfa Olipudase alfa | [1] Olipudase alfa
Olipudase alfa
💬 | [1] SMPD1 SMPD1 💬 | [5] Lysosome Lysosome, Metabolic pathways, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway 💬 | [1] 19 19 💬 |
401 | Olipudase alfa (GZ402665) | [1] Olipudase alfa Olipudase alfa | [1] Olipudase alfa
Olipudase alfa
💬 | [1] SMPD1 SMPD1 💬 | [5] Lysosome Lysosome, Metabolic pathways, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway 💬 | [1] 19 19 💬 |
402 | Olipudase alfa (rhASM) | [1] Olipudase alfa Olipudase alfa | [1] Olipudase alfa
Olipudase alfa
💬 | [1] SMPD1 SMPD1 💬 | [5] Lysosome Lysosome, Metabolic pathways, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway 💬 | [1] 19 19 💬 |
403 | OMNIPAQUE | [1] Iohexol Iohexol | [1] Iohexol
Iohexol
💬 | - | - | [2] 19 19, 222 💬 |
404 | Oral migalastat HCl | [1] Migalastat Migalastat | [1] Migalastat
Migalastat
💬 | - | - | [1] 19 19 💬 |
405 | Osteopetrosis Haploidentical Only Preparative Regimen | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬 |
406 | Osteopetrosis Only Preparative Regimen | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬 |
407 | OTL-200 | - | - | - | - | [1] 19 19 💬 |
408 | OTL-200 Dispersion for Infusion | - | - | - | - | [1] 19 19 💬 |
409 | OTL-200 Gene Therapy | - | - | - | - | [1] 19 19 💬 |
410 | Pabinafusp alfa | [1] Pabinafusp alfa Pabinafusp alfa | [1] Pabinafusp alfa
Pabinafusp alfa
💬 | [2] IDS IDS, TFRC 💬 | [8] Endocytosis Endocytosis, Ferroptosis, Glycosaminoglycan degradation, HIF-1 signaling pathway, Hematopoietic cell lineage, Lysosome, Metabolic pathways, Phagosome 💬 | [1] 19 19 💬 |
411 | PARACETAMOLO | - | - | - | - | [9] 2 2, 11, 14, 19, 28, 53, 61, 63, 300 💬 |
412 | PARACETAMOLO DOC GENERICI - 1000 MG COMPRESSA 16 COMPRESSE | - | - | - | - | [1] 19 19 💬 |
413 | Paricalcitol | [1] Paricalcitol Paricalcitol | [1] Paricalcitol
Paricalcitol
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [5] 19 19, 66, 218, 238, 298 💬 |
414 | PBGM01 | - | - | - | - | [1] 19 19 💬 |
415 | PBKR03 | - | - | - | - | [1] 19 19 💬 |
416 | PEGUNIGALSIDASE ALFA | [1] Pegunigalsidase alfa Pegunigalsidase alfa | [1] Pegunigalsidase alfa
Pegunigalsidase alfa
💬 | - | - | [1] 19 19 💬 |
417 | Pegunigalsidase alpha | - | - | - | - | [1] 19 19 💬 |
418 | Pending | - | - | - | - | [6] 13 13, 19, 96, 97, 113, 302 💬 |
419 | Pentosan Polysulfat SP 54® injection solution | - | - | - | - | [1] 19 19 💬 |
420 | Pentosan polysulfate | [1] Pentosan polysulfate Pentosan polysulfate | - | - | - | [3] 19 19, 26, 226 💬 |
421 | PENTOSAN POLYSULFATE SODIUM | [1] Pentosan polysulfate Pentosan polysulfate | - | - | - | [1] 19 19 💬 |
422 | Pentosan Polysulphate SP54 | - | - | - | - | [1] 19 19 💬 |
423 | Pentosan Polysulphate SP54® | - | - | - | - | [1] 19 19 💬 |
424 | Perdix | - | - | - | - | [1] 19 19 💬 |
425 | Plant cell expressed recombinant glucocerebrosidase (prGCD) | [1] Taliglucerase alfa Taliglucerase alfa | [1] Taliglucerase alfa
Taliglucerase alfa
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
426 | Plant Cell Recombinant Glucocerebrosidase | - | - | - | - | [1] 19 19 💬 |
427 | Plasma Lyso-GB3 | - | - | - | - | [1] 19 19 💬 |
428 | PLX-200 | - | - | - | - | [1] 19 19 💬 |
429 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [45] 2 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 💬 |
430 | PREDNISONE DOC GENERICI - 5 MG COMPRESSE 10 COMPRESSE IN BLISTER PVC-PVDC/ALU | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 19 19 💬 |
431 | Prevenar13 | - | - | - | - | [2] 19 19, 265 💬 |
432 | PrGCD | [1] Taliglucerase alfa Taliglucerase alfa | [1] Taliglucerase alfa
Taliglucerase alfa
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
433 | PROCYSBI | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
434 | PRX-102 | - | - | - | - | [1] 19 19 💬 |
435 | PRX-102 (pegunigalsidase alfa) | [1] Pegunigalsidase alfa Pegunigalsidase alfa | [1] Pegunigalsidase alfa
Pegunigalsidase alfa
💬 | - | - | [1] 19 19 💬 |
436 | PRX-102 1 mg/kg every 2 weeks | - | - | - | - | [1] 19 19 💬 |
437 | PRX-102 2 mg/kg every 4 weeks | - | - | - | - | [1] 19 19 💬 |
438 | PRX-112 | - | - | - | - | [1] 19 19 💬 |
439 | PRX102 | - | - | - | - | [1] 19 19 💬 |
440 | PTC124 | - | - | - | - | [4] 19 19, 113, 246, 299 💬 |
441 | Purified form of the lysosomal enzyme iduronate-2-sulfatase | - | - | - | - | [1] 19 19 💬 |
442 | PYRIMETHAMINE | [1] Pyrimethamine Pyrimethamine | [1] Pyrimethamine
Pyrimethamine
💬 | - | - | [4] 2 2, 4, 19, 65 💬 |
443 | RAAV 2/6 hIDS DONOR | - | - | - | - | [1] 19 19 💬 |
444 | RAAV2/5-hNAGLU | - | - | - | - | [1] 19 19 💬 |
445 | RAAV2/6 Left ZFN Vector | - | - | - | - | [1] 19 19 💬 |
446 | RAAV2/6 Right ZFN Vector | - | - | - | - | [1] 19 19 💬 |
447 | RAAV9.CMV.hNAGLU | - | - | - | - | [1] 19 19 💬 |
448 | Rebisufligene etisparvovec | [1] Rebisufligene etisparvovec Rebisufligene etisparvovec | - | - | - | [1] 19 19 💬 |
449 | Recombinant Adeno-associated virus 2/6 vector encoding the cDNA for human alpha galactosidase A | - | - | - | - | [1] 19 19 💬 |
450 | Recombinant alpha-galactosidase A | [1] Agalsidase alfa Agalsidase alfa | [1] Agalsidase alfa
Agalsidase alfa
💬 | [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
451 | Recombinant human acid sphingomyelinase | - | - | - | - | [1] 19 19 💬 |
452 | RECOMBINANT HUMAN ACID SPHINGOMYELINASE (rhASM) | - | - | - | - | [1] 19 19 💬 |
453 | Recombinant human alpha-galactosidase | - | - | - | - | [1] 19 19 💬 |
454 | Recombinant human alpha-galactosidase abbreviated as r-h-alpha-GAL | - | - | - | - | [1] 19 19 💬 |
455 | Recombinant human alpha-mannosidase | - | - | - | - | [1] 19 19 💬 |
456 | Recombinant Human Alpha-N-Acetylglucosaminidase (rhNAGLU) | - | - | - | - | [1] 19 19 💬 |
457 | RECOMBINANT HUMAN ARYLSULFATASE A | - | - | - | - | [1] 19 19 💬 |
458 | Recombinant Human Arylsulfatase A (rhASA) | - | - | - | - | [1] 19 19 💬 |
459 | Recombinant Human Arylsulfatase A (rhASA, | - | - | - | - | [1] 19 19 💬 |
460 | Recombinant human Arysulfatase B, recombinant human N-acetylgalactosamine 4-sulfatase | - | - | - | - | [1] 19 19 💬 |
461 | RECOMBINANT HUMAN BETA GLUCURONIDASE | - | - | - | - | [1] 19 19 💬 |
462 | Recombinant human beta-glucuronidase | [1] Vestronidase alfa Vestronidase alfa | [1] Vestronidase alfa
Vestronidase alfa
💬 | [1] GUSB GUSB 💬 | [8] Ascorbate and aldarate metabolism Ascorbate and aldarate metabolism, Biosynthesis of cofactors, Drug metabolism - other enzymes, Glycosaminoglycan degradation, Lysosome, Metabolic pathways, Pentose and glucuronate interconversions, Porphyrin metabolism 💬 | [1] 19 19 💬 |
463 | Recombinant human beta-glucuronidase (rhGUS) | [1] Vestronidase alfa Vestronidase alfa | [1] Vestronidase alfa
Vestronidase alfa
💬 | [1] GUSB GUSB 💬 | [8] Ascorbate and aldarate metabolism Ascorbate and aldarate metabolism, Biosynthesis of cofactors, Drug metabolism - other enzymes, Glycosaminoglycan degradation, Lysosome, Metabolic pathways, Pentose and glucuronate interconversions, Porphyrin metabolism 💬 | [1] 19 19 💬 |
464 | Recombinant human betaglucuronidase | - | - | - | - | [1] 19 19 💬 |
465 | Recombinant human derived macrophage-targeted beta-Glucocerebrosidase | - | - | - | - | [1] 19 19 💬 |
466 | Recombinant human derived macrophage-targeted ß-Glucocerebrosidase | - | - | - | - | [1] 19 19 💬 |
467 | Recombinant human glucerebrosidase | - | - | - | - | [1] 19 19 💬 |
468 | Recombinant human glucocerebrosidase | - | - | - | - | [1] 19 19 💬 |
469 | Recombinant Human Glucocerebrosidase (prGCD) | [1] Taliglucerase alfa Taliglucerase alfa | [1] Taliglucerase alfa
Taliglucerase alfa
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
470 | Recombinant human heparan N-sulfatase | - | - | - | - | [1] 19 19 💬 |
471 | Recombinant human heparan N-sulfatase (rhHNS) | - | - | - | - | [1] 19 19 💬 |
472 | Recombinant human heparan N-sulfatase [rhHNS] | - | - | - | - | [1] 19 19 💬 |
473 | Recombinant human heparan Nsulfatase (rhHNS) | - | - | - | - | [1] 19 19 💬 |
474 | Recombinant human lysosomal acid lipase | - | - | - | - | [1] 19 19 💬 |
475 | Recombinant human lysosomal acid lipase (rhLAL) | - | - | - | - | [1] 19 19 💬 |
476 | Recombinant human lysosomal acid lipase (rhLAL), esterase, cholesterol (human gene LIPA) | [1] Cholesterol Cholesterol | [1] Cholesterol
Cholesterol
💬 | - | - | [1] 19 19 💬 |
477 | Recombinant human lysosomal acid lipase (rhLAL), esterase, cholesterol (human gene LIPA), lysosomal acid lipase (human gene LIPA) | [1] Cholesterol Cholesterol | [1] Cholesterol
Cholesterol
💬 | - | - | [1] 19 19 💬 |
478 | Recombinant human lysosomal alpha-mannosidase | - | - | - | - | [1] 19 19 💬 |
479 | Recombinant human N-acetylgalactosamine 4-sulfatase | - | - | - | - | [1] 19 19 💬 |
480 | Recombinant human N-acetylgalactosamine 6-sulfatase, BMN 110 | - | - | - | - | [1] 19 19 💬 |
481 | Recombinant human N-acetylgalactosamine 6-sulfatase, BMN 110 drug substance | - | - | - | - | [1] 19 19 💬 |
482 | Recombinant human N-acetylgalactosamine-6-sulfatase | [1] Elosulfase alfa Elosulfase alfa | [1] Elosulfase alfa
Elosulfase alfa
💬 | [1] GALNS GALNS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
483 | Recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) | [1] Elosulfase alfa Elosulfase alfa | [1] Elosulfase alfa
Elosulfase alfa
💬 | [1] GALNS GALNS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
484 | Recombinant human N-acetylgalactosamine-6-sulfatase, BMN 110 | [1] Elosulfase alfa Elosulfase alfa | [1] Elosulfase alfa
Elosulfase alfa
💬 | [1] GALNS GALNS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
485 | Recombinant human N-acetylgalactosamine-6-sulfatase, BMN 110 drug substance | [1] Elosulfase alfa Elosulfase alfa | [1] Elosulfase alfa
Elosulfase alfa
💬 | [1] GALNS GALNS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
486 | Recombinant human Nacetylgalactosamine- | - | - | - | - | [1] 19 19 💬 |
487 | Recombinant human tripeptidyl peptidase-1 | - | - | - | - | [1] 19 19 💬 |
488 | RECOMBINANT HUMAN TRIPEPTIDYL PEPTIDASE-1 (RHTPP1) | - | - | - | - | [1] 19 19 💬 |
489 | Recombinant self-complementary adeno-associated viral vector serotype 9 containing the human CLN6 gene | - | - | - | - | [1] 19 19 💬 |
490 | Reduced Intensity Conditioning | - | - | - | - | [2] 19 19, 65 💬 |
491 | Reminder capsules | - | - | - | - | [1] 19 19 💬 |
492 | Reminder Product | - | - | - | - | [1] 19 19 💬 |
493 | REPLAGAL | [1] Agalsidase alfa Agalsidase alfa | [1] Agalsidase alfa
Agalsidase alfa
💬 | [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
494 | Replagal (Agalsidase Alfa) | [1] Agalsidase alfa Agalsidase alfa | [1] Agalsidase alfa
Agalsidase alfa
💬 | [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
495 | Replagal agalsidase alfa | [1] Agalsidase alfa Agalsidase alfa | [1] Agalsidase alfa
Agalsidase alfa
💬 | [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
496 | REPLAGAL ® | [1] Agalsidase alfa Agalsidase alfa | [1] Agalsidase alfa
Agalsidase alfa
💬 | [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
497 | RGX-111 | - | - | - | - | [1] 19 19 💬 |
498 | RGX-121 | - | - | - | - | [1] 19 19 💬 |
499 | Rh Growth Hormone | [1] Somatotropin Somatotropin | - | - | - | [1] 19 19 💬 |
500 | RhARSA | - | - | - | - | [1] 19 19 💬 |
501 | RhASA | - | - | - | - | [1] 19 19 💬 |
502 | RhASA - Dose Level 1 | - | - | - | - | [1] 19 19 💬 |
503 | RhASA - Dose Level 2 | - | - | - | - | [1] 19 19 💬 |
504 | RhASA - Dose Level 3 | - | - | - | - | [1] 19 19 💬 |
505 | RhASM | - | - | - | - | [1] 19 19 💬 |
506 | RhGALNS | [1] Elosulfase alfa Elosulfase alfa | [1] Elosulfase alfa
Elosulfase alfa
💬 | [1] GALNS GALNS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
507 | RHGUS | - | - | - | - | [1] 19 19 💬 |
508 | RhHNS-10 mg | - | - | - | - | [1] 19 19 💬 |
509 | RhHNS-45 mg | - | - | - | - | [1] 19 19 💬 |
510 | RhHNS-90 mg | - | - | - | - | [1] 19 19 💬 |
511 | RhIDU (recombinant human-Alpha-L-Iduronidase) | - | - | - | - | [1] 19 19 💬 |
512 | RhLAMAN | [1] Velmanase alfa Velmanase alfa | [1] Velmanase alfa
Velmanase alfa
💬 | [1] MAN2B1 MAN2B1 💬 | [2] Lysosome Lysosome, Other glycan degradation 💬 | [1] 19 19 💬 |
513 | RhNAGLU | - | - | - | - | [1] 19 19 💬 |
514 | RhNAGLU radiolabelled | - | - | - | - | [1] 19 19 💬 |
515 | RHNAGLU-IGF2 | - | - | - | - | [1] 19 19 💬 |
516 | Rimiducid | [1] Rimiducid Rimiducid | [1] Rimiducid
Rimiducid
💬 | [1] CASP9 CASP9 💬 | [35] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Colorectal cancer, Endometrial cancer, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Huntington disease, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Measles, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parkinson disease, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prion disease, Prostate cancer, Small cell lung cancer, Thyroid hormone signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Viral myocarditis, p53 signaling pathway 💬 | [6] 19 19, 60, 65, 284, 285, 326 💬 |
517 | RITUXIMAB | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬 | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [48] 11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
518 | Rivogenlecleucel | - | - | - | - | [4] 19 19, 60, 285, 326 💬 |
519 | RP 103 | - | - | - | - | [2] 8 8, 19 💬 |
520 | RP103 | - | - | - | - | [2] 8 8, 19 💬 |
521 | RVX000222 | - | - | - | - | [1] 19 19 💬 |
522 | SAF-301 | - | - | - | - | [1] 19 19 💬 |
523 | SAR402671, GZ402671 o GZ/SAR402671 | - | - | - | - | [2] 19 19, 67 💬 |
524 | SAR402671, GZ402671 or GZ / SAR402671 | - | - | - | - | [1] 19 19 💬 |
525 | SAR402671, GZ402671 or GZ/SAR402671 | - | - | - | - | [3] 6 6, 19, 67 💬 |
526 | SB-318 | - | - | - | - | [1] 19 19 💬 |
527 | SB-47171 | - | - | - | - | [1] 19 19 💬 |
528 | SB-47898 | - | - | - | - | [1] 19 19 💬 |
529 | SB-913 | - | - | - | - | [1] 19 19 💬 |
530 | SB-A6P-HRL Donor Vector | - | - | - | - | [1] 19 19 💬 |
531 | SB-FIX | - | - | - | - | [1] 19 19 💬 |
532 | SB-IDUA | - | - | - | - | [1] 19 19 💬 |
533 | SBC-102 | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬 | [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 💬 |
534 | SBC-102, recombinant human lysosomal acid lipase | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬 | [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 💬 |
535 | SBC-103 | - | - | - | - | [1] 19 19 💬 |
536 | ScAAV9.CB.CLN6 | - | - | - | - | [1] 19 19 💬 |
537 | ScAAV9.U1A.hSGSH | - | - | - | - | [1] 19 19 💬 |
538 | ScAAV9.U1A.SGSH | - | - | - | - | [1] 19 19 💬 |
539 | Sebelipasa Alfa | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬 | [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 💬 |
540 | Sebelipase Alfa | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬 | [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 💬 |
541 | Sebelipase alfa (SBC-102) | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬 | [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 💬 |
542 | Sebelipase alfa 0.35 mg/kg | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬 | [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 💬 |
543 | Sebelipase alfa 1 mg/kg | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬 | [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 💬 |
544 | Sebelipase alfa 3 mg/kg | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬 | [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 💬 |
545 | SHP611 | - | - | - | - | [1] 19 19 💬 |
546 | SHP675 | - | - | - | - | [1] 19 19 💬 |
547 | Sirolimus | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [35] 13 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 98, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 300, 331 💬 |
548 | SOBI003 | - | - | - | - | [1] 19 19 💬 |
549 | Sofosbuvir | [1] Sofosbuvir Sofosbuvir | [1] Sofosbuvir
Sofosbuvir
💬 | - | - | [1] 19 19 💬 |
550 | Somatropin | [1] Somatotropin Somatotropin | - | - | - | [19] 2 2, 3, 19, 46, 65, 74, 75, 78, 96, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299 💬 |
551 | Somatropin (DNA origin) | [1] Somatotropin Somatotropin | - | - | - | [1] 19 19 💬 |
552 | Ss-mercaptoethylamine Hydrochloride & 2-aminoethanethiol Hydrochloride | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
553 | ST-920 | - | - | - | - | [1] 19 19 💬 |
554 | Stem Cell Transplantation | - | - | - | - | [10] 13 13, 19, 20, 46, 65, 90, 125, 164, 234, 326 💬 |
555 | SUB195712 | - | - | - | - | [1] 19 19 💬 |
556 | TALIGLUCERASE ALFA | [1] Taliglucerase alfa Taliglucerase alfa | [1] Taliglucerase alfa
Taliglucerase alfa
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
557 | Taliglucerase alfa - Recombinant human glucocerebrosidase | [1] Taliglucerase alfa Taliglucerase alfa | [1] Taliglucerase alfa
Taliglucerase alfa
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
558 | TBD | - | - | - | - | [5] 19 19, 86, 90, 276, 299 💬 |
559 | Thiotepa | [1] Thiotepa Thiotepa | [1] Thiotepa
Thiotepa
💬 | - | - | [12] 13 13, 19, 20, 28, 51, 60, 65, 85, 96, 164, 284, 285 💬 |
560 | Thiotepa--escalated dose | [1] Thiotepa Thiotepa | [1] Thiotepa
Thiotepa
💬 | - | - | [4] 19 19, 20, 65, 284 💬 |
561 | Thiotepa--single daily dose | [1] Thiotepa Thiotepa | [1] Thiotepa
Thiotepa
💬 | - | - | [4] 19 19, 20, 65, 284 💬 |
562 | Thyroxine | [1] Levothyroxine Levothyroxine | [1] Levothyroxine
Levothyroxine
💬 | [2] THRA THRA, THRB 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | [1] 19 19 💬 |
563 | Tralesinidase alfa | - | - | - | - | [1] 19 19 💬 |
564 | Transduced CD34+ hematopoietic stem cell | - | - | - | - | [2] 19 19, 20 💬 |
565 | Trappsol Cyclo | - | - | - | - | [1] 19 19 💬 |
566 | TREOSULFAN | [1] Treosulfan Treosulfan | [1] Treosulfan
Treosulfan
💬 | - | - | [6] 13 13, 19, 62, 65, 283, 286 💬 |
567 | Triapin | - | - | - | - | [1] 19 19 💬 |
568 | Triapin& triapin Mite | - | - | - | - | [1] 19 19 💬 |
569 | TSHA-101 | - | - | - | - | [1] 19 19 💬 |
570 | Unrelated Umbilical Cord Blood Transplant | - | - | - | - | [1] 19 19 💬 |
571 | UPLYSO | - | - | - | - | [1] 19 19 💬 |
572 | USAN: sebelipasa alfa | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬 | [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 💬 |
573 | USAN: sebelipase alpha | - | - | - | - | [1] 19 19 💬 |
574 | UX003 | - | - | - | - | [1] 19 19 💬 |
575 | Vector viral adenoasociado de serotipo 9 que contiene el gen de la sulfamidasa humana | - | - | - | - | [1] 19 19 💬 |
576 | VELAGLUCERASE ALFA | [1] Velaglucerase alfa Velaglucerase alfa | [1] Velaglucerase alfa
Velaglucerase alfa
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
577 | Velaglucerasi alfa | - | - | - | - | [1] 19 19 💬 |
578 | VELMANASE ALFA | [1] Velmanase alfa Velmanase alfa | [1] Velmanase alfa
Velmanase alfa
💬 | [1] MAN2B1 MAN2B1 💬 | [2] Lysosome Lysosome, Other glycan degradation 💬 | [1] 19 19 💬 |
579 | Velmanase Alfa (e.g. Lamazym) | [1] Velmanase alfa Velmanase alfa | [1] Velmanase alfa
Velmanase alfa
💬 | [1] MAN2B1 MAN2B1 💬 | [2] Lysosome Lysosome, Other glycan degradation 💬 | [1] 19 19 💬 |
580 | Venglustat | [1] Venglustat Venglustat | [1] Venglustat
Venglustat
💬 | [1] UGCG UGCG 💬 | [2] Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [3] 6 6, 19, 67 💬 |
581 | Venglustat (GZ402671) | [1] Venglustat Venglustat | [1] Venglustat
Venglustat
💬 | [1] UGCG UGCG 💬 | [2] Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
582 | Venglustat GZ402671 | [1] Venglustat Venglustat | [1] Venglustat
Venglustat
💬 | [1] UGCG UGCG 💬 | [2] Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [2] 19 19, 67 💬 |
583 | Venglustat malate | [1] Venglustat Venglustat | [1] Venglustat
Venglustat
💬 | [1] UGCG UGCG 💬 | [2] Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [3] 6 6, 19, 67 💬 |
584 | Venglustat malato | [1] Venglustat Venglustat | [1] Venglustat
Venglustat
💬 | [1] UGCG UGCG 💬 | [2] Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [2] 19 19, 67 💬 |
585 | Vestronidase alfa | [1] Vestronidase alfa Vestronidase alfa | [1] Vestronidase alfa
Vestronidase alfa
💬 | [1] GUSB GUSB 💬 | [8] Ascorbate and aldarate metabolism Ascorbate and aldarate metabolism, Biosynthesis of cofactors, Drug metabolism - other enzymes, Glycosaminoglycan degradation, Lysosome, Metabolic pathways, Pentose and glucuronate interconversions, Porphyrin metabolism 💬 | [1] 19 19 💬 |
586 | Vimizim® (elosulfase alfa) | [1] Elosulfase alfa Elosulfase alfa | [1] Elosulfase alfa
Elosulfase alfa
💬 | [1] GALNS GALNS 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 💬 |
587 | Vitamin D | [2] Cholecalciferol Cholecalciferol, Vitamin D | [1] Cholecalciferol
Cholecalciferol
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [20] 13 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 179, 222, 228, 235, 274, 298, 299 💬 |
588 | VPRIV | [1] Velaglucerase alfa Velaglucerase alfa | [1] Velaglucerase alfa
Velaglucerase alfa
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
589 | VPRIV - 400 U - POLVERE PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO(VETRO) 1 FLACONCINO | [1] Velaglucerase alfa Velaglucerase alfa | [1] Velaglucerase alfa
Velaglucerase alfa
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
590 | VPRIV 400 Units powder for solution of infusion | [1] Velaglucerase alfa Velaglucerase alfa | [1] Velaglucerase alfa
Velaglucerase alfa
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
591 | VPRIV ®, | [1] Velaglucerase alfa Velaglucerase alfa | [1] Velaglucerase alfa
Velaglucerase alfa
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
592 | VPRIV® | [1] Velaglucerase alfa Velaglucerase alfa | [1] Velaglucerase alfa
Velaglucerase alfa
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
593 | VTS-270 | - | - | - | - | [1] 19 19 💬 |
594 | Warfarin | [1] Warfarin Warfarin | [1] Warfarin
Warfarin
💬 | [2] NQO1 NQO1, VKORC1 💬 | [7] Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [11] 6 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91 💬 |
595 | ZAVESCA | [1] Miglustat Miglustat | [1] Miglustat
Miglustat
💬 | [1] UGCG UGCG 💬 | [2] Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [3] 19 19, 256, 299 💬 |
596 | Zavesca (Miglustat) | [1] Miglustat Miglustat | [1] Miglustat
Miglustat
💬 | [1] UGCG UGCG 💬 | [2] Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
597 | ZAVESCA 84CPS 100MG | [1] Miglustat Miglustat | [1] Miglustat
Miglustat
💬 | [1] UGCG UGCG 💬 | [2] Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
598 | Zestoretic 10,20 | [1] Lisinopril Lisinopril | [2] Lisinopril
Lisinopril
,
Lisinopril
💬 | [1] ACE ACE 💬 | [6] Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 19 19 💬 |
599 | ZESTORIC | - | - | - | - | [1] 19 19 💬 |
600 | Zestril | [1] Lisinopril Lisinopril | [2] Lisinopril
Lisinopril
,
Lisinopril
💬 | [1] ACE ACE 💬 | [6] Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [3] 19 19, 67, 222 💬 |